# ERADICATE Hp - Treating Helicobacter Pylori With RHB-105

> **NCT01980095** · PHASE3 · COMPLETED · sponsor: **RedHill Biopharma Limited** · enrollment: 119 (actual)

## Conditions studied

- Dyspepsia
- Helicobacter Pylori Infection

## Interventions

- **DRUG:** RHB-105
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01980095
- **Lead sponsor:** RedHill Biopharma Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-11
- **Primary completion:** 2015-06
- **Final completion:** 2015-08
- **Target enrollment:** 119 (ACTUAL)
- **Last updated:** 2019-09-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01980095

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01980095, "ERADICATE Hp - Treating Helicobacter Pylori With RHB-105". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01980095. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*